Paid Clinical Trials Omaha

Discover 342 paid clinical trials in Omaha, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 342

Observational StudyPancreatic Cancer Early Detection Consortium

Recruiting

Sponsor:

Arbor Research Collaborative for Health

Location:

Omaha NE, Kansas City KS, Bloomington IL, Evanston ILshow 39 more

Code:

NCT04970056

Conditions

Pancreas Cancer

Pancreas Cyst

Pancreatic Ductal Adenocarcinoma

Genetic Predisposition

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

ELANA 841PAT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal

Recruiting

Sponsor:

Carl Zeiss Meditec, Inc.

Location:

Omaha NE, Sioux Falls SD, Bloomington MN, Saint Louis MOshow 10 more

Code:

NCT06264232

Conditions

Cataract Senile

Eligibility Criteria

Sex: All

Age: 22 - 70+

Healthy Volunteers: Not accepted

Interventions

Cataract Surgery

WATER IVWATER IV Prostate Cancer

Recruiting

Sponsor:

PROCEPT BioRobotics

Location:

Omaha NE, Kansas City KS, North Kansas City MO, Kearney NEshow 24 more

Code:

NCT06651632

Conditions

Localized Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 45+

Healthy Volunteers: Not accepted

Interventions

Aquablation Therapy

Radical Prostatectomy

AnifrolumabA 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Omaha NE, Rochester MN, Chicago IL, Aurora COshow 43 more

Code:

NCT06015737

Conditions

Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Anifrolumab

Placebo

Lumbar PunctureThe Effectiveness of a Pediatric Lumbar Puncture Restraint Device

Recruiting

PHASE1

PHASE2

Sponsor:

University of Nebraska

Location:

Omaha NE

Code:

NCT00980070

Conditions

Indication for Lumbar Puncture

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

Interventions

Pediatric Restraint for Lumbar Puncture

Lumbar Puncture Device

Standard of Care

Venetoclax with cBTKiA Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-Line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-Treatment Period.

Recruiting

PHASE2

Sponsor:

Genentech, Inc.

Location:

Omaha NE, Des Moines IA, Grand Island NE, Springdale ARshow 15 more

Code:

NCT06524375

Conditions

Chronic Lymphocytic Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Venetoclax

cBTKi Monotherapy

Ventral IncisionProphylactic Reinforcement of Ventral Abdominal Incisions Trial

Recruiting

Sponsor:

C. R. Bard

Location:

Omaha NE, Kansas City MO, Minneapolis MN, Springfield MOshow 22 more

Code:

NCT03911700

Conditions

Open Midline Laparotomy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Phasix™ Mesh

[225Ac]-FPI-2068A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients with Advanced Solid Tumours

Recruiting

PHASE1

Sponsor:

Fusion Pharmaceuticals Inc.

Location:

Omaha NE, St. Louis MO, Chicago IL, Cleveland OHshow 11 more

Code:

NCT06147037

Conditions

Advanced Solid Tumor

Metastatic Colorectal Carcinoma

Head and Neck Squamous Cell Carcinoma

Non-small Cell Lung Cancer

Pancreatic Ductal Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FPI-2053

[111In]-FPI-2107

[225Ac]-FPI-2068

BirtamimabA Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis

Recruiting

PHASE3

Sponsor:

Prothena Biosciences Ltd.

Location:

Omaha NE, Rochester MN, Milwaukee WI, Goshen INshow 23 more

Code:

NCT04973137

Conditions

Light Chain (AL) Amyloidosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Birtamimab

Placebo

Standard of Care Chemotherapy

INBRX-109Study of INBRX-109 in Conventional Chondrosarcoma

Recruiting

PHASE2

Sponsor:

Inhibrx Biosciences, Inc

Location:

Omaha NE, Iowa City IA, Saint Louis MO, Oklahoma City OKshow 23 more

Code:

NCT04950075

Conditions

Conventional Chondrosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

INBRX-109

Placebo